Related Experiment Videos

Management of thyroid incidentalomas

Robert J Silver1, Sareh Parangi

  • 1Department of Endocrinology, Metabolism, and Diabetes, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA.

Insights

Discovering thyroid incidentalomas requires a systematic approach to identify cancerous nodules. Optimal management involves assessing patient risk, identifying malignancy, and evaluating treatment effectiveness in presymptomatic patients.

Area of Science:

  • Endocrinology
  • Oncology
  • Diagnostic Imaging

Background:

  • Thyroid incidentalomas are common findings during imaging for other conditions.
  • A significant proportion of these nodules may harbor malignancy.
  • Current management strategies lack a universally agreed-upon systematic approach.

Purpose of the Study:

  • To outline an optimal management strategy for incidentally detected thyroid nodules.
  • To guide clinicians in assessing the risk and benefit of intervention for thyroid incidentalomas.
  • To emphasize the need for evidence-based decision-making in managing these findings.

Main Methods:

  • A systematic review of existing literature and clinical guidelines.
  • Formulation of key questions to guide clinical decision-making.
  • Emphasis on data acquisition through national databases and randomized studies.

Main Results:

  • Management should address patient risk, diagnostic accuracy for malignancy, and treatment efficacy in early stages.
  • The cost-effectiveness of presymptomatic treatment requires further investigation.
  • Physician participation in data collection is crucial for advancing knowledge.

Conclusions:

  • A structured approach is necessary for managing thyroid incidentalomas.
  • Further research, including prospective studies and data collection, is essential to refine optimal management strategies.
  • Evidence-based guidelines are needed to balance the benefits of early detection against potential harms and costs.

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...